Targeted Protein Degradation (TPD) is an emerging therapeutic approach that selectively eliminates disease-causing proteins by harnessing the body’s natural protein disposal pathways, primarily the ...

Conference Call and Webcast Today at 8:30 a.m. ETReceived U.S. Food and Drug Administration (FDA) clearance to initiate OCU410 Phase 3 trial for ...

Q2 2026 Earnings Call August 5, 2026 4:30 PM EDTCompany ParticipantsPia Eaves - Vice President of Investor Relations ...

Deucravacitinib shows greater efficacy than placebo in adults with active psoriatic arthritis at week 16, with sustained benefits through week 52 and a well-tolerated safety profile.

Amkor Technology (NASDAQ:AMKR) moves into focus as accelerating AI chip demand lifts the semiconductor packaging and test ...

Thousands of Internet-connected servers sold by the world’s biggest manufacturers can be remotely backdoored by exploiting ...

Bristol Myers Squibb (NYSE:BMY) draws sector attention as reported combination talks with AstraZeneca place the large-cap ...

Patients with high-risk ERBB2-negative breast cancer receive dual checkpoint blockade with cemiplimab and fianlimab in addition to standard neoadjuvant chemotherapy.

Q2 2026 earnings call recap: guidance cut, CEO transition, oncology pipeline updates, and key catalysts—read insights and what’s next.

Citi has told clients that a large chunk of deal risk is already in AstraZeneca PLC's (LSE:AZN, NASDAQ:AZN) share price after Monday's sharp fall, while Deutsche Bank sees clear parallels with the ...

While both drugmakers face looming patent cliffs, analysts say joining forces could help Bristol Myers Squibb replenish its ...

From matching pixel density to choosing the right monitor arms, these are the five decisions that make a multi-monitor setup ...